Literature DB >> 22352392

Rapid determination of isocorydine in rat plasma and tissues using liquid chromatography--tandem mass spectrometry and its applications to pharmacokinetics and tissue distribution.

Changchuan Guo1, Caihong Yu, Li Li, Yuqing Wang, Shengjia Wang, Weihong Wang, Haihong Hu, Siyun Xu, Lushan Yu, Huidi Jiang, Su Zeng.   

Abstract

A rapid and sensitive method for the determination of isocorydine in rat plasma and tissues was developed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The biological samples were processed by extracting with diethyl ether-dichloromethane (3:2, v/v) and tetrahydropulmatine was used as the internal standard (IS). Detection of the analytes was achieved using positive ion mode electrospray ionization in the multiple reaction monitoring mode. The MS/MS ion transitions monitored were m/z 342.0→279.0 and 356.0→191.9 for isocorydine and IS, respectively. The maximum plasma concentration (C(max) 2496.8 ± 374.4 µg/L) was achieved at 0.278 ± 0.113 h (T(max)) and the half-life (t(1/2)) of isocorydine was 0.906 ± 0.222 h after a 20 mg/kg oral administration. As for a 2 mg/kg intravenous (i.v.) administration, the C(max) and clearance (CL) were 1843.3 ± 338.3 µg/L and 2.381 ± 0.356 L/h/kg, respectively. Based on the AUC(0-∞) obtained from oral and i.v. administration, the absolute bioavailability (F) was estimated as 33.4%. Tissue distribution results indicated that isocorydine underwent a rapid and wide distribution into tissues and it could effectively cross the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22352392     DOI: 10.3109/00498254.2011.640965

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Isocorydine derivatives and their anticancer activities.

Authors:  Mei Zhong; Yanjuan Liu; Junxi Liu; Duolong Di; Mengrou Xu; Yaya Yang; Wenguang Li; Yali Chen; Jinxia Liu
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

2.  Effects of 8-Amino-Isocorydine, a Derivative of Isocorydine, on Gastric Carcinoma Cell Proliferation and Apoptosis.

Authors:  Lei Song; Fei Zhao; Yong Liu; Xiaonong Guo; Chengli Wu; Junxi Liu
Journal:  Curr Ther Res Clin Exp       Date:  2021-03-04

3.  Study on pharmacokinetics and tissue distribution of the isocorydine derivative (AICD) in rats by HPLC-DAD method.

Authors:  Yali Chen; Qian Yan; Mei Zhong; Quanyi Zhao; Junxi Liu; Duolong Di; Jinxia Liu
Journal:  Acta Pharm Sin B       Date:  2015-04-16       Impact factor: 11.413

4.  An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.

Authors:  Meng Li; Lixing Zhang; Chao Ge; Lijuan Chen; Tao Fang; Hong Li; Hua Tian; Junxi Liu; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li
Journal:  Oncotarget       Date:  2015-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.